Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
7.16
+0.07 (0.99%)
Nov 5, 2024, 1:19 PM EST - Market open
Annexon Market Cap
Annexon has a market cap or net worth of $756.48 million as of November 5, 2024. Its market cap has increased by 703.06% in one year.
Market Cap
756.48M
Enterprise Value
410.59M
1-Year Change
703.06%
Ranking
Category
Stock Price
$7.16
Market Cap Chart
Since July 24, 2020, Annexon's market cap has increased from $599.60M to $756.48M, an increase of 26.16%. That is a compound annual growth rate of 5.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2024 | 749.10M | 209.93% |
| Dec 29, 2023 | 241.70M | -1.83% |
| Dec 30, 2022 | 246.20M | -44.16% |
| Dec 31, 2021 | 440.90M | -53.84% |
| Dec 31, 2020 | 955.10M | 59.29% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AbCellera Biologics | 804.44M |
| InnovAge Holding | 803.49M |
| Adaptive Biotechnologies | 783.08M |
| Nuvation Bio | 769.99M |
| Erasca | 768.07M |
| LENZ Therapeutics | 767.98M |
| Pacira BioSciences | 764.32M |
| Arbutus Biopharma | 747.58M |